John F. Paolini, CHIEF MEDICAL OFFICER at Kiniksa Pharmaceuticals International, plc (KNSA), sold 122,735 shares at $26.09 ($3.2M) on 2024-09-03, disclosed to the SEC on 2024-09-04.
Scheduled sale ($3.2M) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.74 | 1,994 | $53K | 1.7% |
| 2 | $26.74 | 835 | $22K | 0.7% |
| 3 | $26.09 | 59,214 | $1.5M | 48.2% |
| 4 | $26.09 | 59,214 | $1.5M | 48.2% |
| 5 | $27.13 | 1,478 | $40K | 1.3% |
| Total | $26.12 avg | 122,735 |
| $3.2M |
| 100% |
| Filing → |
| KNSA | SELL | 2025-11-04 | $6.1M | — | Filing → |
| KNSA | SELL | 2025-08-08 | $1.9M | — | Filing → |
| KNSA | SELL | 2025-05-09 | $5K | — | Filing → |